Significantly, BCL6 was also upregulated in CRC tumor samples, and high expression of BCL6 was correlated with poor prognosis of colon cancer patients based on TCGA datasets analysis (Fig. 4b, c). Here, BCL6 is linked to colonic neoplasm.